Oxyphenbutazone: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
|IUPAC_name=4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione | | Verifiedfields = changed | ||
|image=oxyphenbutazone.png | | verifiedrevid = 477171011 | ||
| | | IUPAC_name = (''RS'')-4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione | ||
| | | image = oxyphenbutazone.png | ||
| width = 250px | |||
| imagename = 1 : 1 mixture (racemate) | |||
| drug_name = Oxyphenbutazone | |||
| | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|oxyphenbutazone}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> | |||
| legal_UK = <!-- GSL / P / POM / CD --> | |||
| legal_US = <!-- OTC / Rx-only --> | |||
<!--Identifiers--> | |||
| CASNo_Ref = {{cascite|correct|CAS}} | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 129-20-4 | |||
| ATC_prefix = M01 | |||
| ATC_suffix = AA03 | |||
| ATC_supplemental = {{ATC|M02|AA04}} {{ATC|S01|BC02}} | |||
| PubChem = 104811 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB03585 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 94610 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = A7D84513GV | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D08324 | |||
| ChEBI_Ref = {{ebicite|changed|EBI}} | |||
| ChEBI = 76258 | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 1228 | |||
<!--Chemical data--> | |||
| C=19 | H=20 | N=2 | O=3 | |||
| molecular_weight = 324.379 g/mol | |||
| smiles = O=C2N(c1ccc(O)cc1)N(C(=O)C2CCCC)c3ccccc3.O | |||
| InChI = 1/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2 | |||
| InChIKey = CNDQSXOVEQXJOE-UHFFFAOYAR | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = CNDQSXOVEQXJOE-UHFFFAOYSA-N | |||
}} | |||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Oxyphenbutazone''' is a [[non-steroidal anti-inflammatory drug]] (NSAID). It is a [[metabolite]] of [[phenylbutazone]]. | |||
==Scrabble== | |||
The word ''oxyphenbutazone'' is part of the single play yielding the highest possible score under American tournament [[Scrabble]] rules, scoring 1,780 points across three triple-word-score squares, joining seven tiles to eight already-played tiles. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Anti-inflammatory and antirheumatic products}} | {{Anti-inflammatory and antirheumatic products}} | ||
{{Topical products for joint and muscular pain}} | {{Topical products for joint and muscular pain}} | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
[[Category: | [[Category:Phenols]] | ||
[[Category:Drug]] |
Latest revision as of 15:42, 13 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H20N2O3 |
Molar mass | 324.379 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Oxyphenbutazone |
Articles |
---|
Most recent articles on Oxyphenbutazone Most cited articles on Oxyphenbutazone |
Media |
Powerpoint slides on Oxyphenbutazone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Oxyphenbutazone at Clinical Trials.gov Trial results on Oxyphenbutazone Clinical Trials on Oxyphenbutazone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Oxyphenbutazone NICE Guidance on Oxyphenbutazone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Oxyphenbutazone Discussion groups on Oxyphenbutazone Patient Handouts on Oxyphenbutazone Directions to Hospitals Treating Oxyphenbutazone Risk calculators and risk factors for Oxyphenbutazone
|
Healthcare Provider Resources |
Causes & Risk Factors for Oxyphenbutazone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxyphenbutazone is a non-steroidal anti-inflammatory drug (NSAID). It is a metabolite of phenylbutazone.
Scrabble
The word oxyphenbutazone is part of the single play yielding the highest possible score under American tournament Scrabble rules, scoring 1,780 points across three triple-word-score squares, joining seven tiles to eight already-played tiles.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Non-steroidal anti-inflammatory drugs
- Phenols
- Drug